Long Island, NY, March 1, 2012 – AccuVein Inc., the global leader in vein illumination and the creator of the world’s only hand-held, non-contact vein illumination device, today reported the findings of its study on the impact that vein illumination has on patient preference and overall satisfaction. The study of almost 400 patients exposed to vein illumination, found that not only do patients want vein illumination used for all venipuncture procedures, including IV infusion and blood draw, but that they are willing to change their behavior and specifically seek out facilities that feature the technology.

Patient satisfaction is a key and growing measure of success in healthcare today. Starting in October 2012 as a result of the passage of the Affordable Care Act, Medicare will begin taking patient satisfaction into account when reimbursing hospitals. This program marks the first time that hospitals across the country will be paid for inpatient acute care services based upon care quality, not just the quantity of the services provided. This will create even more competition between hospitals to satisfy patients, with those garnering the best scores receiving more money.

AccuVein’s study found that 93% of patients would give a hospital a higher satisfaction score if vein illumination were utilized. Furthermore, 94% of patients expressed the desire to have vein illumination used each time they were stuck, suggesting a desire to have a facility-wide adoption of the technology. In fact, patients expressed such strong desires about the technology that they said they would be willing to drive an extra 14 miles to go to a hospital that used a vein illumination device such as AccuVein’s.

In addition, patients expressed overwhelmingly positive feelings about the caregivers using vein illumination. Specifically, 98% of patients said they would appreciate the extra effort of a medical care provider who used vein illumination, a strong indication that the use of a vein illumination device could facilitate a more positive nurse/patient interaction.

“Patient satisfaction is increasingly becoming a critical measurement of hospital success and this data suggests that vein illumination devices such as AccuVein’s can have a significant impact and be a key differentiator,” said AccuVein CEO Ron Goldman. “Seeing patients express such a strong preference for vein illumination is encouraging and provides additional support for incorporating vein illumination into the venipuncture standard of care.”
Venipuncture is the most common invasive medical procedure worldwide, with an estimated 2.7 million procedures conducted every day in the United States alone. Studies show that up to one third of the attempts to access a vein fail the first time, creating unnecessary patient discomfort as well as additional costs. Patients overwhelmingly endorse vein illumination because it improves caregivers’ ability to access veins. It does this by projecting a safe pattern of light on a patient’s skin that reveals the position of underlying veins.

To request a copy of the Patient Preference Survey go to http://www.accuvein.com/patient-preference-study/.

About AccuVein Inc.
AccuVein Inc. is a global leader in vein illumination. Its breakthrough product allows health care professionals to see a map of peripheral veins on the skin’s surface with the goal of improving vascular access procedures including blood draw, IV infusion and blood donation.

The device is the world’s only portable, non-contact vein illumination solution. It is built on AccuVein’s proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies.

Vein illumination with AccuVein’s breakthrough device is in use at more than 1,000 hospitals and available for sale in 96 countries worldwide. To see a demonstration of vein illumination with AccuVein, please visit www.accuvein.com.

Long Island, NY, February 9, 2012 – AccuVein Inc., a global leader in medical imaging technology and the creator of the world’s only hand-held, non-contact vein illumination device, today announced that Daniel Delaney has joined the company as Chief Operating Officer. Dan most recently served as Senior Vice President of Alere, Inc. and prior to that, he served as Alere’s President of North America.

Prior to joining Alere Inc./Inverness Medical Innovations in 2004, Mr. Delaney had a successful 20 year career with Abbott Laboratories and Hospira, Inc. where he held various commercial roles of increasing responsibility. These included Business Unit Director, Infusion Therapy (Hospira and Abbott Hospital Products Division), Marketing Manager Immunoassay (Abbott Diagnostics Division) and leadership roles in the commercial organization of Abbott Diagnostics Division.

“We are thrilled to have Dan Delaney join the AccuVein team to help accelerate our worldwide growth. With Dan’s experience in healthcare commercialization and his specific knowledge in the medical device sector, he will be an invaluable asset. His track record of success is among the most impressive I’ve seen in the industry”, said AccuVein CEO Ron Goldman.

“I am excited to be joining a company at the forefront of using patented innovative technology to deliver breakthrough patient care. I am looking forward to assisting AccuVein as it further expands its business globally and explores new products and opportunities for medical imaging”, said Mr. Delaney.

Dan joins AccuVein at a time when patient care, satisfaction and cost reduction are more of a priority than ever for the healthcare industry.  Vein illumination with AccuVein’s breakthrough device helps address these issues by assisting healthcare professionals with vascular access, thereby reducing infection risk, minimizing patient discomfort and expense.

To learn more about vein illumination and AccuVein’s award-winning device, please contact Shep Doniger at 561-637-5750 or visit www.accuvein.com.

About AccuVein Inc.

AccuVein Inc. is a global leader in medical imaging solutions. Its breakthrough product allows health care professionals to see a map of peripheral veins on the skin’s surface with the goal of improving vascular access procedures including blood draw, IV infusion and blood donation.

AccuVein’s vein viewing system is the world’s only portable, non-contact vein illumination solution. It is built on AccuVein’s proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies.

The device is in use at more than 1,000 hospitals and available for sale in 96 countries worldwide. To see a demonstration of vein illumination with the AccuVein, please visit www.accuvein.com.

Tip #4. Invest in Vein Finding Technologies
In venipuncture, you have very little margin for error. That’s even more so the
case in patients with difficult-to-locate veins, such as pediatrics, or in those with
vascular damage, such as chronic steroid users and cancer patients undergoing
radiation therapy. You may want to consider investing in light-based and ultrasound
technologies that can help your staff visualize veins beneath the skin.
Sarah Johnson, RN, perianesthesia nurse manager at the Iowa City (Iowa)
Ambulatory Surgical Center, doesn’t have to imagine how much more effective
she’d be if she could locate the veins beneath the skin. She knows, thanks to the
vein illumination device her facility rents.
You slowly move the handheld device over the appendage in which you
want to start an IV, says Ms. Johnson. The device shines an infrared light that
lets you see the vasculature within that limb. “You can see the vein as it runs
down your arm,” she says. “You can see the bifurcations within the vein and
see if the vein is long enough to hold the catheter. This has been a huge help
for us in minimizing failed attempts, especially in those patients that are more
difficult to get IV starts.”

Read the entire Outpatient Surgery Article, which can be found on page 30.

AccuVein’s units now in use at 10 Banner Health facilities

Long Island, NY — October 12, 2011 — AccuVein Inc., a global leader in medical imaging technology and the creator of the world’s only portable, non-contact vein illumination device, announced today that it will be exhibiting at the Medica World Forum for Medicine Conference being held in Dusseldorf, Germany, November 16-19.  This “world medical trade fair” is  the largest conference of its kind anywhere and has been staged for more than 40 years. This year’s “World of Medica” Conference is expected to draw 4,300 exhibitors and host an estimated 137,000 visitors.

AccuVein will have its vein illumination technology on display in the US Pavilion, Hall 16, Booth16/E40-13. The area is designated for Medical Technology, Electro-medical devices, surgical instruments and related products.

“Our activities at the world-renowned Medica World Forum for Medicine represent our efforts to continue to make vein illumination part of the industry standard of care worldwide ,” said Ron Goldman, AccuVein CEO. “We want healthcare providers  to recognize the vast potential and future medical imaging applications of our technology and this conference is one of the most effective ways to do that on a grand scale.”

AccuVein’s industry-leading and award-winning vein illumination solution is in use at more than 1000 hospitals and available for sale in 96 countries.  The device has been shown to improve peripheral vascular access for IV infusion by projecting a safe pattern of light on patient’s skin that reveals the position of underlying veins.

Venipuncture is the most common invasive medical procedure worldwide with an estimated 2.7 million procedures conducted every day in the United States alone.  Studies show that up to one third of these attempts to access a vein fail the first time, creating unnecessary patient discomfort as well as additional costs.

AccuVein’s vein illumination device has received high praise from doctors, nurses, hospital administrators, patients and families for its ease of use, saving time and money and for improving patient care. The technology has also received numerous awards and widespread recognition from within the health care sector, including the top “gold” prize in the prestigious MDEA design competition as well as the 2011 Frost & Sullivan New Product Innovation Award.

About AccuVein Inc.

AccuVein Inc. is a global leader in medical imaging solutions. Its breakthrough product allows health care professionals to see a map of peripheral veins on the skin’s surface with the goal of improving vascular access procedures including blood draw, IV infusion and blood donation.

Vein illumination with AccuVein’s breakthrough device is the world’s only portable, non-contact vein illumination solution. It is built on AccuVein’s proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies.

Vein illumination with AccuVein’s breakthrough device is in use at more than 1,000  hospitals and available for sale in 96 countries worldwide. To see a demonstration of vein illumination with AccuVein, please visit www.accuvein.com.

For more information and to speak with company officials, please contact Shep Doniger at 561-637-5750 or sdoniger@bdcginc.com.

EMS World Magazine is the leading monthly publication for the Emergency Medical
Services (EMS) market. The Top Innovations Awards recognize the industry’s most
innovative products of the year. EMS World Magazine selected AccuVein’s vein illumination device
from among hundreds of exhibitors at its EMS World Expo touting it as one of its
most innovative products of the year. In making their selections, the
publication seeks out products that help EMS professionals deliver outstanding
patient care.

“EMS specialists deliver patient care under the most extreme conditions. We are
proud of this recognition from industry professionals who provide such critical
care ,” said Ron Goldman, AccuVein CEO. “The device’s portability makes it
uniquely positioned to assist EMS professionals in bringing more accurate and
speedier patient care when time is of the essence.”

“Enerspect is focused on identifying emerging technologies that provide
significant clinical benefit for emergency responders. Feedback from key thought
leaders and early adopters indicated that AccuVein’s device was clearly an
innovative and valuable technology for both patients and providers. We felt it
would be an excellent candidate for the EMS 2011 Top Innovation Award and are
truly pleased that EMS World granted the award,” said Dave Shelton, President
and CEO of Enerspect.

Vein illumination with AccuVein has received high praise from doctors, nurses, hospital
administrators, patients and families for its ease of use, saving time and money
and for improving patient care. The technology has also received numerous awards
and widespread recognition from within the health care sector, including the top
“gold” prize in the prestigious MDEA design competition as well as the 2011
Frost & Sullivan New Product Innovation Award.

AccuVein’s industry-leading and award-winning vein illumination
solution is in use at more than 1000 hospitals and available for sale in 96
countries. The device has been shown to improve peripheral vascular access for IV
infusion by projecting a safe pattern of light on patient’s skin that reveals
the position of underlying veins.

Venipuncture is the most common invasive medical procedure worldwide with an
estimated 2.7 million procedures conducted every day in the United States alone.
Studies show that up to one third of these attempts to access a vein fail the
first time, creating unnecessary patient discomfort as well as additional costs.

About AccuVein Inc.

AccuVein Inc. is a global leader in medical imaging solutions. Its breakthrough
product allows health care professionals to see a map of peripheral
veins on the skin’s surface with the goal of improving vascular access
procedures including blood draw, IV infusion and blood donation.

The device is the world’s only portable, non-contact vein illumination solution.
It is built on AccuVein’s proprietary technology as embodied in its growing
patent portfolio that covers a broad range of imaging and medical diagnostic
technologies.

Vein illumination with AccuVein is in use at more than 1,000 hospitals and available for sale in 96
countries worldwide. To see a demonstration of vein illumination with AccuVein,
please visit www.accuvein.com.

For more information and to speak with company officials, please contact Shep
Doniger at 561-637-5750 or sdoniger@bdcginc.com.

About Enerspect Medical Solutions

Enerspect Medical Solutions, Inc. is located in Henderson, NV. With 30 years of
experience in the emergency medical response market, the Enerspect team offers
solutions focused on strengthening emergency response systems to improve overall
medical outcomes through training and innovative technology solutions.

For more information about the AccuVein AV300 and its successful application in
EMS, please contact Enerspect Medical at (888) 522-5574, or go to
www.enerspect.com.

By Aaron Rowe

November 3, 2011

AccuVein Augmented Reality Vein Viewing System

World’s first and only hand-held, non-contact vein illumination device is among standout technology at world’s leading multi-disciplinary conference on the future of health and medicine

October 12, 2011 by MassDevice staff

Venipuncture – drawing blood or establishing an intravenous feed – is the most common invasive medical procedure. For many patients, it’s a painful exercise in frustration when clinicians struggle to find a blood vessel, sometimes requiring multiple needle sticks.

AccuVein and CEO Ron Goldman aim to change all that with the company’s vascular illumination device. The wireless, handheld module uses a pair of lasers to paint a patient’s arm with light, making otherwise invisible or hard-to-find blood vessels apparent to the naked eye.

“When you draw blood or insert an IV line without vascular illumination, you’re essentially going blind,” Goldman told MassDevice. “With vascular illumination, you simply shine it on the arm and you see the vasculature as though it’s painted right on the body.”

Goldman, an electrical engineer and patent attorney by training, told us he got his first indoctrination into the world of imaging technology as a patent lawyer in Manhattan in the early 1980s. AccuVein’s device is based on the principle that blood absorbs infrared light, Goldman said.

“We line up two lasers, one infrared and one red laser. We very simply are looking for where the infrared light is absorbed,” he explained. “It’s very simple, elegant technology.”

AccuVein drummed up $22.5 million in a Series B round in July, led by MVM Life Science Partners and Bessemer Venture Partners. The device is cleared for sale in at least 88 countries worldwide, including the U.S., India, Russia, Japan and China.

Click here to listen to the MassDevice podcast interview with AccuVein CEO Ron Goldman

Long Island, NY, August 17, 2011 – AccuVein Inc., a global leader in medical imaging technology and the creator of the world’s first hand-held, non-contact vein illumination device, announced today that their device has been approved for sale in China by the State Food and Drug Administration (SFDA). Hong Kong Fortune Life Trade Limited will be the exclusive distributor of the AccuVein vein finder in China.
With the addition of China, AccuVein’s vein illumination device is now available in 88 countries representing two thirds of the world’s population. The AV300 is already being sold in India, Russia, Japan and many other countries. For the full list, please visit http://www.accuvein.com/how-to-buy/international/.

“China is a country of 1.3 billion people where emphasis on quality healthcare continues to rise,” said AccuVein CEO Ron Goldman. “We are excited about the opportunity to positively impact patient care and reduce healthcare costs on such a large scale.”

Venipuncture is the most common invasive medical procedure, with millions of procedures conducted every day around the world. Studies show that up to one third of these attempts to access a vein fail the first time, creating unnecessary patient discomfort, as well as additional costs. The device has been shown to improve peripheral vascular access for IV infusion by projecting a safe pattern of light on a patient’s skin that reveals the position of underlying veins. This can be particularly helpful on patients who have Difficult Venous Access (DVA).

About AccuVein Inc.
AccuVein is a global leader in medical imaging solutions. Its breakthrough product allows health care professionals to see a map of peripheral veins on the skin’s surface with the goal of improving venipuncture and other vascular access procedures. The device is the world’s only handheld, non-contact vein illumination solution. It is built on AccuVein’s proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies. AccuVein has received numerous awards and widespread recognition from within the healthcare sector, including the top “gold” prize in the prestigious MDEA design competition as well as the 2011 Frost & Sullivan New Product Innovation Award. AccuVein’s industry leading and award winning vein illumination solution is in use at more than 750 U.S. hospitals and available for sale in 88 countries. To see the device in action and for a complete listing of countries selling AccuVein’s breakthrough device, visit www.accuvein.com.

About Hong Kong Fortune Life Trade Limited
Hong Kong Fortune Life Trade Limited specializes in the import and export of innovative, high-end medical devices. Partnering with medical institutions, hospitals, research institutes and business units, they are committed to promoting and popularizing high-technology equipment internationally. In order to guarantee the quality of the equipment they represent, Hong Kong Fortune Life Trade Limited works with proven, well-known international top- Fortune 500 companies including General Electric Company (GE), 3M of US, Olympus, and Nikon. For more information visit www.hkfortunelife.com